Key result
Prescription of beta blockers at discharge after acute myocardial infarction was associated with lower 1-year mortality compared to no prescription.
Why the study?
Does prescription of beta blockers at discharge reduce 1-year mortality in survivors of acute myocardial infarction?
Cohort
No
Does prescription of beta blockers at discharge reduce 1-year mortality in survivors of acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Prescription of beta blockers at discharge after acute myocardial infarction is associated with a significantly increased rate of 1-year survival.
Based on selected patient populations, several randomized trials have shown beta blockers to decrease mortality after acute myocardial infarction (AMI). The purpose of this study was to describe the use of beta blockers in various subsets of patients admitted to Sahlgren's Hospital between February 15, 1986, and November 9, 1987, with AMI, and the relation of AMI to other risk indicators for death and to a 1-year mortality rate. Beta blockers, mainly metoprolol, were prescribed for 66% of all survivors at discharge. They were more frequently prescribed for younger patients and for those with a previous history of AMI and hypertension, but less frequently for those with a history of congestive heart failure and diabetes mellitus. Patients for whom beta blockers were not prescribed haa a 1-year mortality of 27% versus 11% for the rest (p < 0.001). Independent predictors of 1-year mortality after discharge were age (p < 0.001), history of hypertension (p < 0.001), prescription of beta blockers at discharge (p < 0.001), congestive heart failure during hospitalization (p < 0.001), and a history of AMI (p < 0.01). P values were corrected for baseline differences. Beta blockers were not prescribed at discharge for one-third of survivors after AMI. This group had a very high mortality during the first year. When simultaneously considering various risk indicators for death, prescription of beta blockers at discharge was associated with an increased rate of survival.
No takes yet. Share an insight, caveat, or question.
Karlson et al. (1994) conducted a cohort in Acute myocardial infarction. Beta blockers vs. No beta blockers prescribed at discharge was evaluated on 1-year mortality (p=<0.001). Prescription of beta blockers at discharge after acute myocardial infarction was associated with lower 1-year mortality compared to no prescription.
Synapse has enriched 10 related papers. Consider them for comparative context: